Skip to main content
. 2017 Nov 17;85(12):e00591-17. doi: 10.1128/IAI.00591-17

FIG 2.

FIG 2

A negligible degree of binding of anti-OmpA MAbs was observed with all A. baumannii clinical isolates tested. Negligible binding of anti-OmpA MAbs (7D4 and 12E11) against all tested encapsulated clinical isolates, including HUMC8 and 899 (K2 capsular serotype), HUMC1 (K4 capsular serotype), 985 (K11 capsular serotype), and 955 (K16 capsular serotype), was found. Binding reactions were assessed by flow cytometry. Mouse IgG1 and IgG2a were used as negative controls. PE-A, phycoerythrin area.